Commercially developed molecular diagnostics are used ubiquitously by laboratories in various healthcare settings to detect, diagnose, and track a wide range of diseases. However, an increasing number of labs opt to develop tests in-house to fulfill unmet diagnostic needs.
Download this ebook from Thermo Fisher Scientific to learn how laboratory developed tests are changing the landscape of molecular diagnostics.
Top Image Credit:
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this Issue
In this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.
Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences.
